Monte Rosa Therapeutics, Inc. (GLUE)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
9. 74
-0.38
-3.7549%
$
870.14M Market Cap
- P/E Ratio
- Div Yield
885,400 Volume
-2.4 Eps
$ 10.12
Previous Close 
Want to track GLUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Monte Rosa Therapeutics, Inc. (GLUE) Statistics
Valuation metrics
Market Cap 870.14M
Enterprise value 778.84M
Trailing P/E (ttm) -4.47
Forward P/E -
PEG ratio 0.54
Price/Sales (ttm) 28.93
Price/Book (mrq) 1.7
Enterprise Value/Revenue 27.11
Enterprise Value/EBITDA -5
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.69M
Average volume (90 days) 1.35M
Price summary
52-Week low 8.94
52-Week high 25.77
Beta -
50-Day moving average 12.11
200-Day moving average 17.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.61%
Operating margin -6.33%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 9.52%
Book value per share (mrq) 5.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
